Inigo Tirapu Fernandez De La Cuesta

Title: Inigo Tirapu Fernandez De La Cuesta: Innovator in Hematological Treatments

Introduction

Inigo Tirapu Fernandez De La Cuesta is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hematological malignancies. His innovative work has led to the development of a unique patent that addresses critical medical needs.

Latest Patents

Inigo holds a patent for "Combinations of LSD1 inhibitors for the treatment of hematological malignancies." This invention relates to combinations of the compound of formula (I) or pharmaceutically acceptable salts thereof with other active pharmaceutical ingredients. The pharmaceutical compositions comprising these combinations are intended for use as medicaments, specifically targeting hematological malignancies.

Career Highlights

Inigo is associated with Oryzon Genomics S.A., a company that focuses on developing innovative therapies for cancer and neurodegenerative diseases. His work at Oryzon has positioned him as a key player in the pharmaceutical industry, contributing to advancements in treatment options for patients.

Collaborations

Inigo collaborates with esteemed colleagues such as Filippo Ciceri and Serena Lunardi. Their combined expertise enhances the research and development efforts at Oryzon, fostering an environment of innovation and discovery.

Conclusion

Inigo Tirapu Fernandez De La Cuesta exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations are paving the way for new treatments in hematological malignancies.